Category: <span>Bellberry Community</span>
Listen to our brand new podcast series, ‘From Lab To Life’, where we go behind the scenes to understand more about the clinical trial and medical research sector. You’ll hear from experts in the sector, including researchers, clinical trial participants and members of Human Research Ethics Committees, exploring challenges and opportunities facing the health and medical research world.
As Bellberry celebrates its 20th year of operation in 2023/24, in this first episode Creating Difference, Bellberry’s CEO, Kylie Sproston talks about what Bellberry is and how it works.
Bellberry are once again delighted to be sponsoring and exhibiting at this years AusBiotech conference. For over 37 years, the AusBiotech conference has served as the leading international meeting place for the Australian life science community. The Ausbiotech conference 2023 is an exciting event that showcases the best and brightest in Australian biotech and science. The conference features a range of speakers and exhibitors from across the biotech and science industries, with a focus on innovation, discovery, and the future of these fields.
Bellberry will be exhibiting at Stand 48. Please come and see the team for further information about our HREC meetings, the application process or just for an informal chat! We look forward to seeing you there.
| Day | Meeting Date | Submission Date |
| Wednesday | 6 December | 22 November |
| Wednesday | 13 December | 29 November |
| Wednesday | 20 December | 6 December |
| Bellberry office closure: Saturday 23 December 2023 to Tuesday 2 January 2024 | ||
| Wednesday | 3 January | 13 December |
| Wednesday | 10 January | 20 December |
| Wednesday | 17 January | 3 January |
| Wednesday | 24 January | 10 January |
HREC meetings are held every Wednesday for the duration of 2024
Bellberry are proud to be a platinum sponsor of AAHMS (Australian Academy of Health and Medical Sciences) 2023. This year’s theme is Driving health equity – a pressing concern globally. This meeting is an opportunity to exchange ideas, consider the latest research findings, and discuss innovative solutions to improve the health outcomes of disadvantaged populations in Australia.
We look forward to seeing you there!
In June 2023 Bellberry were delighted to host the “Towards a Coordinated Approach for Managing Accelerated Patient Access to Potentially Beneficial Medicines: Balancing Patient, Regulator, Health Technology Assessment (HTA), Payer, and Other Stakeholder Needs” international workshop in Adelaide.
This event brought together over a global delegation from over 20 nations including the US, UK, Europe, Canada, Singapore, and Japan from a range of stakeholder groups to discuss the issue of a gap in funded access to potentially beneficial medicines where there has been accelerated regulatory approval. All aspects of the workshop programme were overseen by a Scientific Committee and were chaired by E/Prof Lloyd Sansom.
The workshop was followed by a one-day open day meeting where the deliberations and conclusions of the expert panel presented and debated amongst a wider local audience. The workshop outcome was the development of an agreed statement of good practice, guidelines on approaches and a clear agreement on required next steps.
The full report from the workshop can now be viewed here, key themes from the report were integrated into a meeting statement that can be viewed here.
Bellberry is a values-driven organisation working in research ethics, where respect is a fundamental principle that guides the work that we do. Bellberry is committed, through our work, and the principles enshrined in the NHMRC National Statement, to people having a voice in decisions that affect them. The Voice is a step that Australia can take to embody those principles.
Bellberry is proud to confirm its support for the proposed constitutional amendment to recognise Aboriginal and Torres Strait Islander Peoples as the First Peoples of Australia. This support aligns with our work in research ethics, and the work that we are undertaking as part of our Reconciliation Action Plan.
Bellberry recognises that there will be a diversity of views among its staff, members, and broader community. Every Australian will come to their own decision on the referendum and Bellberry respects this and their right to vote in accordance with those views.
Issued by the Board of Bellberry, September 2023| Day | Meeting Date | Submission Date |
| Wednesday | 6 December | 22 November |
| Wednesday | 13 December | 29 November |
| Wednesday | 20 December | 6 December |
| Bellberry office closure: Saturday 23 December 2023 to Tuesday 2 January 2024 | ||
| Wednesday | 3 January | 13 December |
| Wednesday | 10 January | 20 December |
| Wednesday | 17 January | 3 January |
| Wednesday | 24 January | 10 January |
HREC meetings are held every Wednesday for the duration of 2024

Bellberry were thrilled to win the 2023 Not-For-Profit Business of the Year Award at Friday’s South Australian Premier’s Business and Export Awards!
What a great way to kick off our 20th year celebrations – thanks to our amazing Bellberry community.

Bellberry is exhibiting at SALHN (Southern Adelaide Local Health Network) Research Week this Wednesday the 20th September – come and visit us at this exciting event showcasing local and international talent in health and medical research!

| Day | Meeting Date | Submission Date |
| Wednesday | 6 December | 22 November |
| Wednesday | 13 December | 29 November |
| Wednesday | 20 December | 6 December |
| Bellberry office closure: Saturday 23 December 2023 to Tuesday 2 January 2024 | ||
| Wednesday | 3 January | 13 December |
| Wednesday | 10 January | 20 December |
| Wednesday | 17 January | 3 January |
| Wednesday | 24 January | 10 January |
HREC meetings are held every Wednesday for the duration of 2024
Bellberry are proud to be a Bronze sponsor of the TROG (Trans Tasman Radiation Oncology Group) Annual Scientific Meeting 2023 which is being held here in Adelaide, 19 – 22 June.
The conference theme Accelerating Forward, demonstrates the need for us to have a vision to keep moving forward in cancer research and work together to explore emerging and innovative topics in radiation medicine research. The TROG ASM Organising Committee are expecting over 250 delegates making it an excellent networking and research engagement opportunity.
We look forward to seeing you there!
The 2023 ARCS Annual Conference (6–8 June 2023) will be held at the International Convention Centre (ICC), Darling Harbour, Sydney. The ARCS Annual Conference brings together industry professionals, consumers, patients, practitioners, researchers and academia to unite, educate, inform and network.
Bellberry is delighted to be attending, speaking and exhibiting at ARCS this year. Come and pay us a visit at booth #43. We’d be happy to chat with you about any questions you have regarding your study, your application, our processes and anything else we may be able to support you and your research project with.
We look forward to seeing many new, and familiar faces!
On Monday in celebration of International Clinical Trials Day on 20 May, the Bellberry team supported and acknowledged all the amazing achievements that result from clinical research, by hosting a clinical trials themed afternoon tea.
Andy Phay, Cancer Clinical Research Manager at SA Health joined us for a discussion about the key considerations and priorities when running a clinical trial, followed by a presentation and learning’s from the Ethics Working Group in AI Translational Health Research in Singapore by Lisa Eckstein (Director of Philanthropy at Bellberry) and an update on Confidentiality and Privacy in a Landscape of Emerging Technologies from Franco Boschiero (IT Business Partner at Bellberry).
We were also proud to publish the Bellberry Clinical Trial Activity Report for 2022. This annual publication represents over one third of the Australia wide CTN trial activity across the development lifecycle.
Click here to register and download the Bellberry Clinical Trial Activity Report 2022
On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report for 2022. This annual publication represents over one third of the Australia wide CTN trial activity across the development lifecycle.
This report demonstrates capability and capacity in a broad range of research areas. It also captures the originating funding location for inward investment in Sponsored clinical trials, again demonstrating Australia’s active participation in the global development process.
In this reporting period Bellberry was also delighted to have been awarded full re-accreditation for five years by the global Association for the Accreditation of Human Research Protection Programs (AAHRPP). Bellberry is the only organisation to achieve AAHRPP accreditation reflecting Bellberry’s commitment to protecting the rights and welfare of research participants.
If you have any questions relating to this data, please contact us at bellberry@bellberry.com.au
Click here to register and download the Bellberry Clinical Trial Activity Report 2022
Discover the latest in Medical Technology at the 2023 AusMedtech Conference in Adelaide. With expert keynotes, panel discussions, and Q&A sessions, you’ll gain insights into the trends and breakthroughs that are propelling the industry forward.
Register now to discover a strong line up of speakers on topics that include Australian manufacturing success stories, navigating the distribution landscape, the evolving diagnostics landscape, the changing IP landscape and more.
REGISTER NOW! We look forward to seeing you there.


